NGS 샘플 조제 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The NGS Sample Preparation Market size is expected to reach USD 10.69 Billion in 2034 from USD 3.38 Billion (2025) growing at a CAGR of 13.66% during 2026-2034.

The global next-generation sequencing (NGS) sample preparation market is experiencing rapid growth due to the increasing adoption of genomic technologies in research and clinical applications. Sample preparation is a critical step in NGS workflows, ensuring accurate and reliable sequencing results. The growing demand for personalized medicine and genetic testing is driving market expansion. Additionally, advancements in sequencing technologies are increasing the need for efficient and high-quality sample preparation solutions.

Key growth drivers include rising investments in genomics research and the increasing use of NGS in disease diagnosis and drug development. Automation in sample preparation processes is improving efficiency and reducing human error. The expansion of applications in oncology, infectious diseases, and rare genetic disorders is also contributing to market growth. Furthermore, collaborations between research institutions and biotechnology companies are accelerating innovation in this field.

Looking ahead, the NGS sample preparation market is expected to grow significantly with ongoing advancements in genomics and biotechnology. The development of faster and more cost-effective preparation techniques will enhance accessibility. Emerging markets are likely to provide substantial growth opportunities due to increasing research activities and healthcare investments. Additionally, the integration of artificial intelligence and automation will further improve workflow efficiency and accuracy.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Service

• Workstations/Instruments
• Reagents & Consumables
• Services

By Workflow

• DNA Fragmentation & Library Preparation
• Target Enrichment
• Quality Control

By Sample Type

• DNA
• RNA

By Application

• Disease Diagnostics
• Drug Discovery
• Agricultural and Animal Research
• Other applications

By Method

• Manual Sample Preparation
• Microfluidic Sample Preparation
• Automated Liquid Handling-based Sample Preparation

By End User

• Hospitals & Clinics
• Academic Institutes & Research Centers
• Pharmaceutical & Biotechnology Companies
• Other End Users

COMPANIES PROFILED

• Illumina Inc, Thermo Fisher Scientific Inc, F HoffmannLa Roche Ltd, PerkinElmer Inc, Agilent Technologies Inc, Danaher Corporation, Becton, Dickinson and Company, QIAGEN NV, Merck KGaA, BioRad Laboratories Inc, Promega Corporation, Eurofins Scientific, BGI Group, 10x Genomics Inc, Sysmex Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NGS SAMPLE PREPARATION MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Workstations/Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NGS SAMPLE PREPARATION MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Workflow
• 5.2. DNA Fragmentation & Library Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Target Enrichment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Quality Control Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NGS SAMPLE PREPARATION MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Sample Type
• 6.2. DNA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. RNA Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NGS SAMPLE PREPARATION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Disease Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Agricultural and Animal Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL NGS SAMPLE PREPARATION MARKET: BY METHOD 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Method
• 8.2. Manual Sample Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Microfluidic Sample Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Automated Liquid Handling-based Sample Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL NGS SAMPLE PREPARATION MARKET: BY END USER 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End User
• 9.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Academic Institutes & Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL NGS SAMPLE PREPARATION MARKET: BY REGION 2022-2034 (USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product & Service
  • 10.2.2 By Workflow
  • 10.2.3 By Sample Type
  • 10.2.4 By Application
  • 10.2.5 By Method
  • 10.2.6 By End User
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product & Service
  • 10.3.2 By Workflow
  • 10.3.3 By Sample Type
  • 10.3.4 By Application
  • 10.3.5 By Method
  • 10.3.6 By End User
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product & Service
  • 10.4.2 By Workflow
  • 10.4.3 By Sample Type
  • 10.4.4 By Application
  • 10.4.5 By Method
  • 10.4.6 By End User
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product & Service
  • 10.5.2 By Workflow
  • 10.5.3 By Sample Type
  • 10.5.4 By Application
  • 10.5.5 By Method
  • 10.5.6 By End User
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Product & Service
  • 10.6.2 By Workflow
  • 10.6.3 By Sample Type
  • 10.6.4 By Application
  • 10.6.5 By Method
  • 10.6.6 By End User
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL NGS SAMPLE PREPARATION INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Illumina Inc
  • 12.2.2 Thermo Fisher Scientific Inc
  • 12.2.3 F. Hoffmann-La Roche Ltd
  • 12.2.4 PerkinElmer Inc
  • 12.2.5 Agilent Technologies Inc
  • 12.2.6 Danaher Corporation
  • 12.2.7 Becton
  • 12.2.8 Dickinson And Company
  • 12.2.9 QIAGEN N.V
  • 12.2.10 Merck KGaA
  • 12.2.11 Bio-Rad Laboratories Inc
  • 12.2.12 Promega Corporation
  • 12.2.13 Eurofins Scientific
  • 12.2.14 BGI Group
  • 12.2.15 10x Genomics Inc
  • 12.2.16 Sysmex Corporation